To confirm and compare the effect of Nrf2-inducers on FA neuroprotection, we also treated frataxin-silenced neurons with dimethyl fumarate (DMF), a drug already in use for the treatment of multiple sclerosis and recently proposed as a therapy for PD [20]. The gene discussed is NFE2L2; the disease is Parkinson disease.